Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus pred...

por Romero-Laorden, Nuria, Lozano, Rebeca, Jayaram, Anuradha, López-Campos, Fernando, Saez, Maria I., Montesa, Alvaro, Gutierrez-Pecharoman, Ana, Villatoro, Rosa, Herrera, Bernardo, Correa, Raquel, Rosero, Adriana, Pacheco, María I., Garcés, Teresa, Cendón, Ylenia, Nombela, Ma Paz, Van de Poll, Floortje, Grau, Gala, Rivera, Leticia, López, Pedro P., Cruz, Juan-Jesús, Lorente, David, Attard, Gerhardt, Castro, Elena, Olmos, David
Publicado 2018